Company: MDCXW
Filing Date: 2025-09-29
Form Type: S-1
Source: 0001062993-25-015839
Chunk: 3

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-29
Form: S-1
Chunk 3
---
 shares by the Selling Shareholder and any discounts, commissions, or concessions received by the Selling Shareholder are deemed to be underwriting discounts and commissions under the Securities Act. We will pay the expenses incurred in registering under the Securities Act the offer and sale of the common shares to which this prospectus relates by the Selling Shareholder, including our legal and accounting fees. The Selling Shareholder will pay all brokerage fees and commissions and similar expenses in connection with the offer and sale of the common shares by the Selling Shareholder pursuant to this prospectus.

Our common shares are listed on The Nasdaq Capital Market (the “Nasdaq”), under the symbol “MDCX.” The closing price of our common shares on the Nasdaq on September 26, 2025 was $2.63.

We are an "emerging growth company" and a "smaller reporting company" under applicable U.S. Securities and Exchange Commission ("SEC") rules and will be eligible for reduced public company disclosure requirements. See"Prospectus Summary-Implications of Being an Emerging Growth Company" and "Prospectus Summary-Implications of Being a Smaller Reporting Company."

Investing in our securities involves risks. See "Risk Factors" beginning on page 10 of this prospectus to read about factors you should consider before buying our securities.

Neither the SEC nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is , 2025

TABLE OF CONTENTS</div>

| CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS                              | iii |
| PROSPECTUS SUMMARY                                                                     |   1 |
| THE OFFERING                                                                           |   7 |
| SELECTED HISTORICAL CONSOLIDATED FINANCIAL INFORMATION                                 |   8 |
| RISK FACTORS                                                                           |  10 |
| DIVIDEND POLICY                                                                        |  46 |
| USE OF PROCEEDS                                                                        |  47 |
| MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION  AND RESULTS OF OPERATIONS |  48 |
| OUR BUSINESS                                                                           |  59 |
| MANAGEMENT                                                                             | 104 |
| SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT                         | 130 |
| RELATED PARTY TRANSACTIONS                                                             | 132 |
| DESCRIPTION OF SECURITIES                                                              | 134 |
| CERTAIN MATERIAL U